Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
November 24, 2015
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators
René Blöcher, Christina Lamers, Sandra K Wittmann, et al.
Journal of Medicinal Chemistry
|
January 13, 2025
Identification of a Chemical Probe for BLT2 Activation by Scaffold Hopping
Victor Hernandez-Olmos, Jan Heering, Niklas Ildefeld, et al.
Journal of Medicinal Chemistry
|
October 12, 2020
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
Kerstin Hiesinger, Jan S Kramer, Sandra Beyer, et al.
Journal of Medicinal Chemistry
|
April 22, 2026
Structure Merging Approach Leads to New Dual Potent and Selective USP25/USP28 Inhibitors
Victor Hernandez-Olmos, Jonathan Vincent Patzke, Caroline E Stone, et al.
Journal of Medicinal Chemistry
|
November 24, 2021
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors
Felix F Lillich, Sabine Willems, Xiaomin Ni, et al.
Journal of Medicinal Chemistry
|
August 23, 2019
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain
Jan S Kramer, Stefano Woltersdorf, Thomas Duflot, et al.
British Journal of Pharmacology
|
November 20, 2024
The endocannabinoid anandamide mediates anti-inflammatory effects through activation of NR4A nuclear receptors
Tom Teichmann, Beatrice Pflüger-Müller, Virna Margarita Martín Giménez, et al.
Journal of Medicinal Chemistry
|
June 25, 2024
Development of a Potent and Selective G2A (GPR132) Agonist
Victor Hernandez-Olmos, Jan Heering, Beatrice Marinescu, et al.
Nature Communications
|
November 25, 2024
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pockets
Martin P Schwalm, Johannes Dopfer, Adarsh Kumar, et al.
International Journal of Cancer
|
February 27, 2015
FAM96A is a novel pro-apoptotic tumor suppressor in gastrointestinal stromal tumors
Bettina Schwamb, Robert Pick, Sara Beatriz Mateus Fernández, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
November 24, 2015
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators
René Blöcher, Christina Lamers, Sandra K Wittmann, et al.
Journal of Medicinal Chemistry
|
January 13, 2025
Identification of a Chemical Probe for BLT2 Activation by Scaffold Hopping
Victor Hernandez-Olmos, Jan Heering, Niklas Ildefeld, et al.
Journal of Medicinal Chemistry
|
October 12, 2020
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
Kerstin Hiesinger, Jan S Kramer, Sandra Beyer, et al.
Journal of Medicinal Chemistry
|
April 22, 2026
Structure Merging Approach Leads to New Dual Potent and Selective USP25/USP28 Inhibitors
Victor Hernandez-Olmos, Jonathan Vincent Patzke, Caroline E Stone, et al.
Journal of Medicinal Chemistry
|
November 24, 2021
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors
Felix F Lillich, Sabine Willems, Xiaomin Ni, et al.
Journal of Medicinal Chemistry
|
August 23, 2019
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain
Jan S Kramer, Stefano Woltersdorf, Thomas Duflot, et al.
British Journal of Pharmacology
|
November 20, 2024
The endocannabinoid anandamide mediates anti-inflammatory effects through activation of NR4A nuclear receptors
Tom Teichmann, Beatrice Pflüger-Müller, Virna Margarita Martín Giménez, et al.
Journal of Medicinal Chemistry
|
June 25, 2024
Development of a Potent and Selective G2A (GPR132) Agonist
Victor Hernandez-Olmos, Jan Heering, Beatrice Marinescu, et al.
Nature Communications
|
November 25, 2024
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pockets
Martin P Schwalm, Johannes Dopfer, Adarsh Kumar, et al.
International Journal of Cancer
|
February 27, 2015
FAM96A is a novel pro-apoptotic tumor suppressor in gastrointestinal stromal tumors
Bettina Schwamb, Robert Pick, Sara Beatriz Mateus Fernández, et al.
Page
of 8